StockNews.com assumed coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright initiated coverage on shares of Celsion in a research report on Tuesday, May 17th. They set a “buy” rating […]
